ストックスクリーナーアプリを入手
8.055
2.83%
-0.235
前日終値:
$8.29
開ける：
$8.22
24時間の取引高:
4.38M
Relative Volume:
0.44
時価総額：
$8.54B
収益：
$140.98M
当期純損益:
$-854.60M
株価収益率:
-9.4321
EPS:
-0.854
ネットキャッシュフロー:
$-299.31M
1週間 パフォーマンス:
+1.32%
1か月 パフォーマンス:
+5.43%
6か月 パフォーマンス:
-4.67%
1年 パフォーマンス:
+213.42%
1日の値動き範囲:
$8.03
$8.36
1週間の範囲:
$7.88
$8.37
52週間の値動き範囲:
$1.95
$12.43
Immunitybio Inc Stock (IBRX) Company Profile
Compare IBRX vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
8.055 | 8.79B | 140.98M | -854.60M | -299.31M | -0.854 |
VRTX
Vertex Pharmaceuticals Inc
|
521.42 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
804.80 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.54 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.41 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.85 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | 再開されました | BTIG Research | Buy |
| 2025-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-10 | 開始されました | BTIG Research | Buy |
| 2023-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 開始されました | Jefferies | Buy |
すべてを表示
Immunitybio Inc (IBRX) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) to British Pound Sterling Price Today | Live IBRX to GBP Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Indonesian Rupiah Price Today | Live IBRX to IDR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to South Korean Won Price Today | Live IBRX to KRW Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Canadian Dollar Price Today | Live IBRX to CAD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to United States Dollar Price Today | Live IBRX to USD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Vietnamese Dong Price Today | Live IBRX to VND Converter & Exchange Rate - CryptoRank
IBRX Stock Climbs Overnight: ImmunityBio Declares ‘All Systems Go’ For Dunkirk Anktiva Manufacturing Push - Stocktwits
ImmunityBio Founder Pushes Back After FDA Warning Letter Over Anktiva Claims — Says Ad 'Never Aired At All' - Stocktwits
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation | NDAQ:IBRX | Press Release - Stockhouse
IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth Catalyst - Stocktwits
IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease - Stocktwits
IBRX Stock Slips Overnight: Founder Teases Turkey Push, Says AI Cancer Cell Robot Is ‘Almost There’ - Stocktwits
IBRX|Immunitybio Inc|Price:8.080|Chg%:-0.110 - TradingKey
Historical Data for ImmunityBio, Inc. Tokenized Stock (Robinhood) in USD - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) Exchanges IBRX Markets | Buy & Sell & Trade - CryptoRank
Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report? - Yahoo Finance
ImmunityBio: None Of The Moonshots Is Priced In (NASDAQ:IBRX) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Investors to Connect - ACCESS Newswire
IBRX to IDR: ImmunityBio, Inc. • Robinhood Token Price in Indonesian Rupiah - CoinGecko
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Stockholders to Connect - ACCESS Newswire
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) Closing Price (USD)Quarterly - CryptoRank
ImmunityBio Stock Short Interest Falls to 31.8% - quiverquant.com
ImmunityBio: ANKTIVA Is Real, The Valuation Isn't (NASDAQ:IBRX) - Seeking Alpha
ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer - Eastern Progress
ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - Morningstar
IBRX Stock Eyes Best Week Since February: Founder Highlights New Anktiva-NK Cell Therapy Study - Stocktwits
IBRX Stock In Spotlight As FDA Scrutiny Prompts ImmunityBio To Withdraw Content, Tighten Oversight - Stocktwits
ImmunityBio (NASDAQ:IBRX): What Could Shape Its Next Move? - Kalkine Media
ImmunityBio, Inc. (NASDAQ:IBRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Patrick Soon-Shiong to Thomas Ichim: Thanks for Sharing Important Difference Between Il-2 and Il-15 - Oncodaily
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Class A - The National Law Review
ImmunityBio (IBRX) Shares Moved, What Is Behind The Fresh Attention? - Sahm
147,000 Shares in ImmunityBio, Inc. $IBRX Purchased by Hussman Strategic Advisors Inc. - MarketBeat
Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)? - simplywall.st
IBRX Founder Soon-Shiong Bets On Anktiva's Next Growth Phase — ImmunityBio Posts Record Q2 Sales - Stocktwits
IBRX Stock In Spotlight: ImmunityBio To Unveil Fresh Anktiva And BCG Data Next Week - Stocktwits
IBRX Stock Price Prediction 2025-2026 | Immunitybio Inc Forecast - 24/7 Wall St.
ImmunityBio, Inc. (IBRX) options chain - Yahoo Finance UK
ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring A 70% Upside Potential - DirectorsTalk Interviews
Jim Yong Kim Joins ImmunityBio as Vice Chairman - Oncodaily
ImmunityBio, Inc. • Robinhood Token (IBRX) Price Prediction for 2026 to 2031 - bybit.com
Archer Aviation (NYSE: ACHR) Among IBRX, JOBY, SCKT Leading Technology Stocks – Plus More in Focus - FinancialContent
ImmunityBio (IBRX) Tests Its Valuation After UAE ANKTIVA Approval Expands Its Reach - Sahm
ImmunityBio Names Former World Bank President Jim Yong Kim Vice Chairman - citybiz
ImmunityBio appoints Jim Yong Kim as vice chairman - Investing.com
ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman - ImmunityBio
Royal Bank of Canada Has $11.40 Million Holdings in ImmunityBio, Inc. $IBRX - MarketBeat
Immunitybio Inc (IBRX) 財務データ
収益
当期純利益
現金流量
EPS
Immunitybio Inc (IBRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cohen Cheryl | Director |
Jul 02 '26 |
Sale |
9.50 |
131,210 |
1,246,941 |
125,386 |
| Selecky Christobel | Director |
Jul 01 '26 |
Option Exercise |
2.99 |
159,478 |
476,489 |
159,478 |
| Selecky Christobel | Director |
Jul 01 '26 |
Sale |
9.02 |
159,478 |
1,439,066 |
0 |
0.61%
3.65%
大文字化:
|
ボリューム (24 時間):